Results 121 to 130 of about 20,592,540 (288)

In silico and in vitro exploration of a tyrosinase for biocatalytic production of catechols

open access: yesFEBS Open Bio, EarlyView.
Tyrosinase from Ralstonia pseudosolanacearum is a promising biocatalyst for producing valuable catechols from monophenol substrates. This tyrosinase is uniquely suited to this due to its high monophenolase : diphenolase ratio. We combined in silico docking and in vivo kinetic characterisation of this tyrosinase with 11 industrially relevant monophenols,
James Britton   +6 more
wiley   +1 more source

Why we do need a new gold open access journal called "Brain, behavior and immunity - Health". [PDF]

open access: yesBrain Behav Immun Health, 2020
Cattaneo A   +3 more
europepmc   +1 more source

Identification and characterisation of calcitonin receptor isoforms expressed in glioblastoma derived glioma stem and U‐87 MG cells

open access: yesFEBS Open Bio, EarlyView.
Glioblastoma cells express calcitonin receptor variants (CT receptor isoforms) that may help them survive stress. Using qPCR, transcript‐specific long‐read nanopore sequencing, immunofluorescence co‐localisation and comparative sequence analysis, this study identifies a novel alternatively spliced CALCR transcript that encodes the CTb receptor isoform ...
Pragya Gupta   +7 more
wiley   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

Gold Open Access Publishing in Mega Journals

open access: yesJournal of Scholarly Publishing, 2017
Open access publishing (OAP) makes research output freely available, and several national governments have now made OAP mandatory for all publicly funded research. Gold OAP is a common form of OAP where the author pays an article processing charge (APC) to make the article freely available to readers. However, gold OAP is a cause for concern because it
Ellers, J., Crowther, T.W., Harvey, J.A.
openaire   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon   +11 more
wiley   +1 more source

Open Access in the biomedical field: a unique opportunity for researchers (and research itself) [PDF]

open access: yes, 2007
Aim of this article is to offer an overview of the Open Access strategy and its innovative idea of a free scholarly communication. Following the worldwide debate on the crisis of the scholarly communication and the new opportunities of a networked ...
Giglia, Elena
core   +1 more source

Empfehlungen für die Umsetzung von Open Access in Österreich

open access: yesMitteilungen der Vereinigung Österreichischer Bibliothekarinnen und Bibliothekare, 2015
Gestützt auf 16 Empfehlungen sollten Anstrengungen gemacht werden, um folgendes Ziel zu erreichen: Bis 2025 ist die gesamte wissenschaftliche Publikationstätigkeit in Österreich auf Open Access umgestellt.
Bruno Bauer   +13 more
doaj  

Green and Gold: the possible futures of Open Access

open access: yes, 2015
Provoked by Mike Eisen's post today, The inevitable failure of parasitic green open access, I want to briefly lay out the possible futures of scholarly publishing as I see them.
openaire   +1 more source

Home - About - Disclaimer - Privacy